In our study, we comprehensively analyzed the expression and prognostic relevance of ST3GAL family members in multiple independent ccRCC datasets, revealing that ST3GAL5 could be a potential prognostic biomarker. This evidence concerns the gene ST3GAL5 and nonpapillary renal cell carcinoma.